PYXS compared with CRDF: revenue, margins and what each company keeps, and the suppliers and customers both name

PYXSPyxis Oncology, Inc.

Mkt capRevenueRevenue

CRDFCardiff Oncology, Inc.

Mkt capRevenueRevenue

Compare

PYXSPyxis Oncology, Inc.

CRDFCardiff Oncology, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PYXS2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−3.01%—

Q2 FY26±30.0%▼−5.35%×0.18

CRDF

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±17.0%▼−5.67%×0.34

Q1 FY26±15.5%▼−3.47%×0.23

= impliedPYXS realized, solidCRDF realized, hatchedOne scale, both sides: full bar = 57%× = |realized| ÷ impliedspan: PYXS 84d · CRDF 378dSource: market data

Q3 FY25

±13.7%

▼−2.67%

×0.20

Jul 30 '25±56.5%▼−24.77%×0.44

PYXSPyxis Oncology, Inc.

1.65▲+2.48%· post 1.70

Mkt cap$138.6MRevenue$389,000Q2 FY26Revenue$13MFY25

CRDFCardiff Oncology, Inc.

0.79▲+4.58%· post 0.79

ClosedNov 6 '26

Mkt cap$61.9MRevenue$104,000Q2 FY26Revenue$593,000FY25

Compare

ClosedNov 6 '26

PYXSPyxis Oncology, Inc.

CRDFCardiff Oncology, Inc.

1.65▲+2.48%post 1.70

Price

0.79▲+4.58%post 0.79

$138.6M

Mkt cap

$61.9M

Q2 FY26$389,000

Revenue

$104,000Q2 FY26

FY25$13M

Revenue

$593,000FY25

PYXS1.65▲+2.48%vsCRDF0.79▲+4.58%ClosedNov 6 '26